Rocket Pharmaceuticals (RCKT) PT Lowered to $69 at JPMorgan, Following Earnings

February 25, 2021 12:57 PM EST Send to a Friend
JPMorgan analyst Eric Joseph lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login